DE60118483T2 - Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung - Google Patents
Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung Download PDFInfo
- Publication number
- DE60118483T2 DE60118483T2 DE60118483T DE60118483T DE60118483T2 DE 60118483 T2 DE60118483 T2 DE 60118483T2 DE 60118483 T DE60118483 T DE 60118483T DE 60118483 T DE60118483 T DE 60118483T DE 60118483 T2 DE60118483 T2 DE 60118483T2
- Authority
- DE
- Germany
- Prior art keywords
- particles
- composition
- dialysis
- sugar
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 95
- 238000000502 dialysis Methods 0.000 title claims description 56
- 239000007787 solid Substances 0.000 title claims description 53
- 238000000034 method Methods 0.000 title claims description 20
- 239000000203 mixture Substances 0.000 claims description 87
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 56
- 239000002245 particle Substances 0.000 claims description 55
- 235000000346 sugar Nutrition 0.000 claims description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 38
- 239000007771 core particle Substances 0.000 claims description 38
- 239000003792 electrolyte Substances 0.000 claims description 31
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 29
- 238000002156 mixing Methods 0.000 claims description 28
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 28
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 28
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 24
- 239000007864 aqueous solution Substances 0.000 claims description 24
- 239000011780 sodium chloride Substances 0.000 claims description 19
- 239000001632 sodium acetate Substances 0.000 claims description 18
- 235000017281 sodium acetate Nutrition 0.000 claims description 18
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 16
- 239000011247 coating layer Substances 0.000 claims description 16
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 14
- 239000001103 potassium chloride Substances 0.000 claims description 14
- 235000011164 potassium chloride Nutrition 0.000 claims description 14
- 239000001110 calcium chloride Substances 0.000 claims description 13
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 12
- 235000011148 calcium chloride Nutrition 0.000 claims description 10
- 235000011147 magnesium chloride Nutrition 0.000 claims description 10
- 238000005507 spraying Methods 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000005469 granulation Methods 0.000 description 12
- 230000003179 granulation Effects 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 9
- 229960002713 calcium chloride Drugs 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 229960002337 magnesium chloride Drugs 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229960002816 potassium chloride Drugs 0.000 description 7
- -1 Calcium chloride anhydride Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229960004249 sodium acetate Drugs 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical group O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 4
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 4
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 4
- 238000005550 wet granulation Methods 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 238000007908 dry granulation Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- CZMRCDWAGMRECN-UHFFFAOYSA-N 2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 229960002668 sodium chloride Drugs 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- YMIFCOGYMQTQBP-UHFFFAOYSA-L calcium;dichloride;hydrate Chemical compound O.[Cl-].[Cl-].[Ca+2] YMIFCOGYMQTQBP-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000293329A JP3899506B2 (ja) | 2000-09-27 | 2000-09-27 | 固形透析用製剤およびその製造方法 |
| JP2000293329 | 2000-09-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60118483D1 DE60118483D1 (de) | 2006-05-18 |
| DE60118483T2 true DE60118483T2 (de) | 2006-10-19 |
Family
ID=18776140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60118483T Expired - Lifetime DE60118483T2 (de) | 2000-09-27 | 2001-09-24 | Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6923987B2 (enExample) |
| EP (1) | EP1192961B1 (enExample) |
| JP (1) | JP3899506B2 (enExample) |
| DE (1) | DE60118483T2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05000816A (es) | 2002-07-19 | 2005-04-28 | Baxter Int | Sistemas y metodos para realizar dialisis peritoneal. |
| WO2004066977A1 (ja) * | 2003-01-31 | 2004-08-12 | Manac Inc. | 透析用固形剤及びその製造方法 |
| WO2004067014A1 (ja) * | 2003-01-31 | 2004-08-12 | Manac Inc. | 透析用固形剤およびその製造方法 |
| KR20060129363A (ko) * | 2004-02-09 | 2006-12-15 | 니프로 가부시키가이샤 | 투석용 고형제제 및 그 제조방법 |
| US20070231395A1 (en) * | 2004-03-30 | 2007-10-04 | Toshiya Kai | Solid Pharmaceutical Preparation for Dialysis |
| JP2007032601A (ja) * | 2005-07-22 | 2007-02-08 | Inaba Denki Sangyo Co Ltd | 貫通孔閉塞具及びそれを用いた貫通孔閉塞構造 |
| TWI516284B (zh) * | 2007-05-31 | 2016-01-11 | 味之素股份有限公司 | 透析用固態製劑 |
| US7736328B2 (en) | 2007-07-05 | 2010-06-15 | Baxter International Inc. | Dialysis system having supply container autoconnection |
| US10973968B2 (en) | 2008-02-14 | 2021-04-13 | Baxter International Inc. | Control of a water device via a dialysis machine user interface |
| US7892423B2 (en) | 2008-02-14 | 2011-02-22 | Baxter International Inc. | Dialysis system including multi-heater power coordination |
| US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
| PL2585076T3 (pl) | 2010-06-23 | 2015-08-31 | Gambro Lundia Ab | Kompozycja prekursora do dializy |
| EP2585039B1 (en) | 2010-06-23 | 2018-04-25 | Gambro Lundia AB | Dialysis precursor composition |
| DE102010039489A1 (de) | 2010-08-18 | 2012-02-23 | Fresenius Medical Care Deutschland Gmbh | Konzentrat |
| WO2012175354A1 (en) | 2011-06-20 | 2012-12-27 | Gambro Lundia Ab | Dialysis precursor composition |
| WO2012175353A1 (en) | 2011-06-20 | 2012-12-27 | Gambro Lundia Ab | Dialysis precursor composition |
| ES2684218T3 (es) | 2011-12-21 | 2018-10-01 | Gambro Lundia Ab | Composición precursora de diálisis |
| US9463202B2 (en) | 2011-12-21 | 2016-10-11 | Gambro Lundia Ab | Dialysis precursor composition |
| SE536913C2 (sv) | 2012-03-08 | 2014-10-28 | Gambro Lundia Ab | Komposition för dialys |
| AU2013201546B2 (en) | 2012-12-18 | 2014-10-23 | Gambro Lundia Ab | Dialysis composition |
| EP2905039A1 (en) * | 2014-02-07 | 2015-08-12 | Fresenius Medical Care Deutschland GmbH | Dry Acid Concentrate in Granulate form |
| US10105299B2 (en) * | 2014-04-10 | 2018-10-23 | The Research Foundation for The State University o f New York | Method of using sonochemical activaction to form meta-stable substances |
| CN104586884A (zh) * | 2015-01-09 | 2015-05-06 | 李淑秀 | 新型血液透析浓缩液 |
| JP2018524718A (ja) | 2015-06-25 | 2018-08-30 | ガンブロ・ルンディア・エービーＧａｍｂｒｏ Ｌｕｎｄｉａ Ａｂ | 分散データベースを有する医療装置システム及び方法 |
| JP6936250B2 (ja) | 2016-05-06 | 2021-09-15 | ガンブロ ルンディア アー・ベー | 使用場所での透析流体調製を有し、かつその試験を含む腹膜透析のためのシステムおよび方法 |
| CN110100283B (zh) | 2016-12-21 | 2023-07-04 | 甘布罗伦迪亚股份公司 | 包括具有支持外域的安全集群域的信息技术基础架构的医疗设备系统 |
| CN109223822A (zh) * | 2018-11-16 | 2019-01-18 | 秦皇岛迈淩医疗设备有限公司 | 一种血液透析用固体制剂及其制备方法 |
| CN111943234A (zh) * | 2020-08-13 | 2020-11-17 | 河北华晨药业有限公司 | 一种制备大粒径药用级无菌碳酸氢钠颗粒的方法 |
| JP7450957B2 (ja) * | 2022-04-08 | 2024-03-18 | 富田製薬株式会社 | 血液透析用ａ剤及び血液透析用剤 |
| KR20260066100A (ko) * | 2023-09-07 | 2026-05-12 | 후소 야쿠힝 고교 가부시끼가이샤 | 혈액투석용 a제 및 혈액투석용 제제 |
| CN122438677A (zh) | 2023-12-27 | 2026-07-21 | 万益特美国保健有限责任公司 | 用于腹膜透析的固体药物制剂及其生产方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4756838A (en) * | 1980-02-21 | 1988-07-12 | Veltman Preston Leonard | Preparation of dry dialysate products |
| US4784495A (en) * | 1987-02-06 | 1988-11-15 | Gambro Ab | System for preparing a fluid intended for a medical procedure by mixing at least one concentrate in powder form with water |
| AU627309B2 (en) * | 1989-05-26 | 1992-08-20 | Terumo Kabushiki Kaisha | Preparation for blood dialysis and method for production thereof |
| JP2769592B2 (ja) * | 1992-12-14 | 1998-06-25 | 富田製薬株式会社 | 重炭酸透析用人工腎臓灌流用剤の製造方法及び人工腎臓灌流用剤 |
| JP2002102336A (ja) * | 2000-09-27 | 2002-04-09 | Nipro Corp | 固形透析用製剤およびその製造方法 |
-
2000
- 2000-09-27 JP JP2000293329A patent/JP3899506B2/ja not_active Expired - Lifetime
-
2001
- 2001-09-24 DE DE60118483T patent/DE60118483T2/de not_active Expired - Lifetime
- 2001-09-24 EP EP01122540A patent/EP1192961B1/en not_active Expired - Lifetime
- 2001-09-27 US US09/963,570 patent/US6923987B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20020061338A1 (en) | 2002-05-23 |
| DE60118483D1 (de) | 2006-05-18 |
| JP2002102337A (ja) | 2002-04-09 |
| US6923987B2 (en) | 2005-08-02 |
| EP1192961A3 (en) | 2002-08-07 |
| EP1192961B1 (en) | 2006-04-05 |
| EP1192961A2 (en) | 2002-04-03 |
| JP3899506B2 (ja) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60009791T2 (de) | Feste pharmazeutische Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung | |
| DE69022884T2 (de) | Zubereitung für die Hemodialyse und deren Produktionsmethode. | |
| DE2749751C3 (de) | Verfahren zur Konservierung von Schmelzkäse | |
| DE60101192T2 (de) | Feste Zubereitung für die Dialyse und Herstellungsverfahren hierfür | |
| DE69531957T2 (de) | Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung | |
| DE69407404T2 (de) | Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung | |
| US6923987B2 (en) | Solid preparation for dialysis and process for producing the same | |
| DE69313798T2 (de) | Dialysatkomponente für die Bicarbonatdialyse und Methode zu seiner Herstellung | |
| DE69018172T2 (de) | Natriumbicarbonat enthaltende Zusammensetzung zur Herstellung einer Dialyselösung. | |
| DE60105807T2 (de) | Verfahren zur Herstellung einer stabilen pharmazeutischen Zusammensetzung enthaltend mikronisiertes Formoterol | |
| DE2725390C2 (enExample) | ||
| DE69705106T2 (de) | Darmreiniger auf Basis von umhülltem Natriumphosphat | |
| DE2058434A1 (de) | Freifliessende,leicht benetzbare Acetylsalicylsaeure enthaltende Teilchen | |
| DE1930957B2 (de) | Wasserlösliches Silbersalz ent haltendes Gel zur Behandlung von Ver brennungen | |
| DE69102900T2 (de) | Brausemischung, deren Herstellung sowie Verwendung. | |
| DE69624364T2 (de) | Abführmittel enthaltend lactitol und psyllium | |
| DE1542340C3 (de) | Verfahren zur Verhinderung des Zusammenbackens eines pulverförmiger! Feststoffs | |
| DE69734532T2 (de) | Futterzusätze für wiederkäuer | |
| CH640731A5 (de) | Ueberzugsmittel fuer feste medikamente. | |
| DE2639505B2 (enExample) | ||
| DE3324209A1 (de) | Suloctidil enthaltende, oral verabfolgbare arzneimittel mit verzoegerter wirkstoffabgabe | |
| DE60009414T2 (de) | Natiumbikarbonat enthaltende feste Arzneistoffzubereitung zur Dialyse und Verfahren zum Herstellung derselben | |
| DE10221863A1 (de) | Phospholipidische Zusammensetzung sowie deren Verwendung | |
| DE69209228T2 (de) | Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe | |
| DE1097963B (de) | Verfahren zur Herstellung von nicht hygroskopischen frei fliessenden, kondensierten glasigen Phosphaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |